GAL3ST1 and Alzheimer disease: Specifically, a mouse model with inducible CST gene deletion specifically in oligodendrocytes has achieved about 50% reduction of sulfatides in the brain, which is comparable to the pattern of sulfatide loss seen in human AD brains [175, 180].